|
CA3114265A1
|
|
Selection of cancer mutations for generation of a personalized cancer vaccine
|
|
AU2019361280A1
|
|
Teleost invariant chain cancer vaccine
|
|
WO2019086615A1
|
|
Vaccine t cell enhancer
|
|
SG11202003609VA
|
|
Eukaryotic cell line
|
|
CA3069051A1
|
|
Neoantigen vaccine composition for treatment of cancer
|
|
KR20200029443A
|
|
Universal vaccine based on a shared tumor neoantigen for the prevention and treatment of microsatellite instability (MSI) cancer
|
|
AU2018295421A1
|
|
Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
|
